Jamal Mohammadian Selected Research

Neoplasms (Cancer)

6/2023	Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor.
1/2023	ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma.
12/2021	Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG2 cancer cells.
1/2021	Sensitization of A-549 lung cancer cells to Cisplatin by Quinacrine-loaded lipidic nanoparticles via suppressing Nrf2 mediated defense mechanism.
12/2020	Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells.
1/2019	Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis.
11/2017	Fabrication of all-trans-retinoic acid-loaded biocompatible precirol: A strategy for escaping dose-dependent side effects of doxorubicin.
12/2016	Folate-Targeted Nanostructured Lipid Carriers (NLCs) Enhance (Letrozol) Efficacy in MCF-7 Breast Cancer Cells
11/2016	Combined Treatment with Stattic and Docetaxel Alters the Bax/Bcl-2 Gene Expression Ratio in Human Prostate Cancer Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jamal Mohammadian Research Topics

Disease

9	Neoplasms (Cancer) 06/2023 - 11/2016
6	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2016
2	Lung Neoplasms (Lung Cancer) 06/2023 - 01/2021
1	COVID-19 05/2023
1	Hepatocellular Carcinoma (Hepatoma) 12/2021
1	Melanoma (Melanoma, Malignant) 12/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 11/2016
1	Leukemia 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 08/2017
4	LipidsIBA 12/2020 - 09/2016
4	statticIBA 12/2020 - 11/2016
2	Docetaxel (Taxotere)FDA Link 06/2023 - 11/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 06/2023
1	remdesivirIBA 05/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2023
1	Circulating Tumor DNAIBA 01/2023
1	Zoledronic Acid (Zometa)FDA Link 12/2021
1	EnzymesIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	Quinacrine (Mepacrine)IBA 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	precirolIBA 11/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2017
1	Cholecalciferol (Vitamin D3)FDA Link 08/2017
1	Vitamin D FDA LinkGeneric 08/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2016
1	Lipid NanoparticlesIBA 12/2016
1	MelatoninIBA 09/2016
1	Tamoxifen FDA LinkGeneric 09/2016
1	Taxoids (Taxanes)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016

Therapy/Procedure

4	Therapeutics 12/2020 - 11/2016
1	Drug Therapy (Chemotherapy) 12/2016